Join the club for FREE to access the whole archive and other member benefits.

ARDD 2021 - 8th Aging Research and Drug Discovery Meeting

Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.

31-Aug-2021 to 03-Sep-2021

According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 8th Aging Research and Drug Discovery Meeting.

Chaired by:
Morten Scheibye-Knudsen - University of Copenhagen
Daniela Bakula - University of Copenhagen
Alex Zhavoronkov - Insilico Medicine

Speakers on this event are:
• Adam Antebi
• Alexey Moskalev
• Anastasia Georgievskaya
• Andrea Meier
• Anne Brunet
• Bjoern Schumacher
• Brian Chen
• Brian Kennedy
• Cai Shiqing
• Christian Riedel
• Collin Ewald
• Dario Valenzano
• David Sinclair
• Emmanuelle Passegue
• Eric Verdin
• Felipe Cabreiro
• Gerard Karsenty
• Guido Kroemer
• James Kirkland
• Jan Hoeijmakers
• Jan Vijg
• Jens Bruning
• Joseph A. Baur
• Kristen Fortney
• Laura Niedernhofer
• Luigi Ferrucci
• Manuel Serrano
• Maria Carolina Florian
• Maria Ermolaeva
• Martin Borsch Jensen
• Michael Kjaer
• Nir Barzilai
• Pam Taub
• Peter de Keizer
• Riekelt Houtkooper
• Rochelle Buffenstein
• Rudi Westendorp
• Simon Holst Bekker-Jensen
• Suresh Rattan
• Thomas Rando
• Tony Wyss-Coray
• Vadim Gladyshev
• Valter Longo
• Vera Gorbunova

Visit website: http://www.agingpharma.org/speakers

 agingpharma

 ARDD2021

See also: Academia University of Copenhagen - Public research university

Details last updated 24-Apr-2021

Interested in more events? View the club's event calendar.

Mentioned in this Resource

Alex Zhavoronkov

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation

BIOAGE

Developing a broad pipeline of therapies to extend human healthspan and lifespan

Bjoern Schumacher

Professor for Genome Stability in Aging and Disease at the University of Cologne

Christian Riedel

Group Leader at Karolinska Institutet.

Daniela Bakula

Assistant professor at Center for Healthy Aging, University of Copenhagen

Deep Longevity

AI to track the rate of ageing at the molecular, cellular, tissue, organ, system, physiological, and psychological levels

Filipe Cabreiro

Principal Investigator at Imperial College London.

FOXO Technologies

Modernizing the longevity insurance industry with molecular biotechnology

Guido Kroemer

Professor at the University of Paris Descartes

Haut.AI

Company providing artificial intelligence application for skincare.

Insilico Medicine

Biotechnology company that uses artificial intelligence to develop new drugs and for aging research

Jan Hoeijmakers

Professor of Molecular Genetics at Erasmus Medical Center Rotterdam.

Jens Bruning

Director at the Max Planck Institute for Metabolism Research.

Molecule

Software platform to accelerate innovation in the pharmaceutical industry.

Morten Scheibye-Knudsen

Head of the Biology of Ageing Laboratory at the University of Copenhagen

OneSkin Technologies

Company that designs anti-aging molecules that fights with skin aging

Peter de Keizer

Associate Professor at UMC Utrecht, Founder and Managing Director at Cleara Biotech

Riekelt Houtkooper

Professor of Translational Metabolism at AMC.

Sable Systems Europe GmbH

Developing and marketing, unmatched in its reliability & precision, instrumentation for metabolic and behavior measurement.

Thomas A. Rando

Professor of Neurology at Stanford University

ARDD 2021 - 8th Aging Research and Drug Discovery Meeting News

Insilico raises $255M to advance human trials and AI drug discovery platform

Insilico raises $255M to advance human trials and AI drug discovery platform

Longevity Technology - 22-Jun-2021

New collab with Teva Pharmaceuticals to identify drug targets for various diseases

Topics mentioned on this page:
Ageing Research, Big Pharma